Devices/Safety Alert·MedWatch

Anesthesia Workstation Correction: Draeger Issues Correction for Atlan A350 and A350 XL

HighPublished Apr 14, 2026· AI-analyzed May 4, 2026View original FDA source
AI-generated regulatory interpretation. The four sections below are an analyst-style summary produced by an AI model from the original FDA source. Always verify against the source before any regulatory, clinical, or commercial decision.
What happened

Draeger issued a correction for Atlan A350 and A350 XL anesthesia workstations due to manufacturing impurities that can lead to piston ventilator failures and mechanical ventilation issues.

Who it affects

Healthcare facilities utilizing Dräger Atlan A350 and A350 XL anesthesia workstations, as well as clinical engineering and anesthesia departments responsible for device maintenance and operation.

Why it matters

The presence of manufacturing impurities leading to mechanical failure indicates a potential gap in quality control or supplier management. For regulatory professionals, this suggests a critical safety risk where the device may fail to provide respiratory support, potentially necessitating an urgent field safety corrective action (FSCA) or recall.

Practical takeaway

Biomedical and QA teams should immediately identify affected Atlan units, sequester devices if required by the manufacturer's specific instructions, and establish a plan for remediation or replacement of ventilator components. Clinical staff should be briefed on the signs of piston failure and readiness of backup ventilation methods.

FDA source material

Draeger corrects the Atlan A350, A350 XL for piston ventilator failures and mechanical ventilation issues due to manufacturing impurities <br>

Open in openFDA / FDA.gov
AI-generated interpretation. Always verify critical decisions against the original FDA source. Generated with google/gemini-3-flash-preview.